A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/32 (2006.01)
Patent
CA 2654584
The present application describes extending survival in a cancer patient, where the patient is producing an elevated level of EGF or TGF-alpha, by treating the patient with a HER dimerization inhibitor, such as pertuzumab.
La présente demande de brevet concerne la prolongation de la survie d'un patient cancéreux, lorsque le patient présente un niveau élevé des facteurs de croissance EGF ou TGF-alpha, par le traitement du patient avec un inhibiteur de dimérisation de HER, tel que du pertuzumab.
Amler Lukas C.
Moecks Joachim
Rabbee Nusrat
Strauss Andreas
F.hoffmann - La Roche Ag
Genentech Inc.
Smart & Biggar
LandOfFree
Extending survival of cancer patients with elevated levels... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extending survival of cancer patients with elevated levels..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extending survival of cancer patients with elevated levels... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1604373